Nucleic Acid Vaccine Patent Application
Summary
USPTO published patent application US20260091104A1 filed by ModernaTX, Inc. for nucleic acid vaccine compositions and methods. The application (No. 19188713) covers ribonucleic acid vaccines encoding antigens, filed on April 24, 2025, and lists three inventors: Giuseppe Ciaramella, Axel Bouchon, and Eric Yi-Chun Huang.
What changed
ModernaTX filed a patent application with USPTO for compositions and methods relating to nucleic acid (RNA) vaccines comprising polynucleotide molecules encoding antigens. The published application (US20260091104A1) covers CPC classifications including A61K 39/145 (influenza), A61K 31/7105 (RNA), and C12N 7/00 (viruses), among others. This is a standard patent publication with no regulatory compliance requirements.
No action is required by any regulated entity. This document represents a private intellectual property filing and does not impose obligations, deadlines, or penalties. Companies developing similar vaccine technologies should review the published claims to assess potential patent overlap, but this application does not trigger any regulatory reporting or compliance obligations.
Archived snapshot
Apr 2, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NUCLEIC ACID VACCINES
Application US20260091104A1 Kind: A1 Apr 02, 2026
Assignee
ModernaTX, INC.
Inventors
Giuseppe CIARAMELLA, Axel BOUCHON, Eric YI-CHUN HUANG
Abstract
The invention relates to compositions and methods for the preparation, manufacture, and therapeutic use of ribonucleic acid vaccines comprising polynucleotide molecules encoding one or more antigens.
CPC Classifications
A61K 39/145 A61K 9/0019 A61K 9/1271 A61K 9/5123 A61K 9/5146 A61K 31/7105 A61K 39/12 A61K 39/155 A61K 39/39 A61K 48/00 C12N 7/00 A61K 2039/53 A61K 2039/545 A61K 2039/55555 C12N 2760/16122 C12N 2760/16134 C12N 2760/16234
Filing Date
2025-04-24
Application No.
19188713
Related changes
Get daily alerts for ChangeBridge: Patent Apps - Biotech (C12N)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The plain-English summary, classification, and "what to do next" steps are AI-generated from the original text. Cite the source document, not the AI analysis.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ChangeBridge: Patent Apps - Biotech (C12N) publishes new changes.